James Blanco
Family Medicine · St. Petersburg, FLNPI 1235353269
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,061 of the $13,725 with a category attached, or 87.9%. It is spread thinly across 60 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 608 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$3K
- Lilly USA, LLC$1K
- Pfizer$760
- Daiichi Sankyo Inc.$733
- Johnson & Johnson$717
- AstraZeneca$714
- plus $6K from 54 others
What the payments were for
- Food & beverage$12,06188%
- Education$3843%
- Other$1,2809%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$13,725 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CalquenceAcalabrutinib Maleate | 28 | $411,556 |
| RevlimidLenalidomide | 19 | $410,018 |
| CabometyxCabozantinib S-Malate | 12 | $289,047 |
| ImbruvicaIbrutinib | 13 | $213,014 |
| ProcritEpoetin Alfa | 15 | $47,915 |
| EliquisApixaban | 25 | $26,857 |
| Anastrozole | 164 | $3,065 |
| Hydroxyurea | 53 | $1,746 |
| Ondansetron OdtOndansetron | 31 | $745 |
| Penicillin V Potassium | 23 | $277 |
| Methylprednisolone | 12 | $129 |
| Ciprofloxacin Hcl | 11 | $86 |
| Warfarin Sodium | 12 | $59 |
| Levothyroxine Sodium | 12 | $54 |
| Folic Acid | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaCalquence | $714 | $411,55628 claims |
| Pharmacyclics LLC, An Abbvie CompanyImbruvica | $100 | $213,01413 claims |
| Johnson & JohnsonProcrit | $717 | $47,91515 claims |
| PfizerEliquis | $760 | $26,85725 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $42 | $5412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in St. Petersburg
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.